Prostatic acid phosphatase (112-120)

Prostatic acid phosphatase (112-120) is a synthetic peptide fragment corresponding to amino acids 112 through 120 of the human prostatic acid phosphatase (PAP) protein. As a defined peptide epitope, it represents a segment of a well-characterized enzyme predominantly expressed in prostate tissue and implicated in various physiological and pathological processes. The highly specific sequence of this peptide makes it a valuable tool for research into the structure, function, and immunogenic properties of PAP, enabling detailed investigations into molecular interactions, enzyme regulation, and antigenic determinants relevant to prostate biology and disease.

Epitope mapping: The peptide segment serves as a precise probe for epitope mapping studies, allowing researchers to delineate antibody recognition sites within the prostatic acid phosphatase protein. By utilizing this defined sequence, investigators can characterize the binding specificity of monoclonal or polyclonal antibodies generated against PAP, facilitating the development of highly selective immunoassays and advancing our understanding of immune recognition mechanisms in prostate-associated antigens.

Antibody production: As an immunogenic peptide, the 112-120 fragment is frequently employed as an antigen for raising sequence-specific antibodies in animal models. Such antibodies are instrumental in detecting or quantifying PAP in various experimental settings, including Western blotting, immunohistochemistry, and ELISA. The use of a synthetic peptide ensures high specificity and reduces cross-reactivity, supporting the generation of reliable research reagents for prostate biology studies.

T-cell response studies: The defined amino acid sequence of this peptide allows its application in cellular immunology research, particularly for studying T-cell recognition and activation. By presenting the peptide in the context of major histocompatibility complex (MHC) molecules, researchers can evaluate T-cell responses to PAP-derived epitopes, shedding light on immune surveillance, tolerance, or autoimmunity in the context of prostate tissue and related pathologies.

Protein-protein interaction analysis: The peptide can be used as a molecular tool to investigate protein-protein or protein-ligand interactions involving the PAP enzyme. By immobilizing or labeling the fragment, scientists can probe binding partners, decipher interaction motifs, and study the structural determinants governing PAP association with regulatory proteins or inhibitors, thereby elucidating mechanisms of enzyme function and modulation.

Peptide-based assay development: The unique sequence and defined length of the 112-120 fragment support its use in the development of peptide-based analytical assays. These assays may include competitive binding platforms, peptide arrays, or biosensor formats designed to detect specific interactions, screen for inhibitors, or quantify antibody responses. The use of a synthetic, well-characterized peptide enhances assay reproducibility and enables high-throughput screening applications in basic and translational research focused on prostatic acid phosphatase.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)